These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 851115)

  • 1. Drug distribution in renal failure.
    Gibaldi M
    Am J Med; 1977 Apr; 62(4):471-4. PubMed ID: 851115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug protein binding and the nephrotic syndrome.
    Gugler R; Azarnoff DL
    Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of drugs in patients with the nephrotic syndrome.
    Gugler R; Shoeman DW; Huffman DH; Cohlmia JB; Azarnoff DL
    J Clin Invest; 1975 Jun; 55(6):1182-9. PubMed ID: 1133166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the pharmacokinetics of drugs in renal failure].
    Nadzhimutdinov KN; Krakovskiĭ ME
    Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139
    [No Abstract]   [Full Text] [Related]  

  • 5. The biotransformation of drugs in renal failure.
    Reidenberg MM
    Am J Med; 1977 Apr; 62(4):482-5. PubMed ID: 851117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in renal disease.
    Levy G
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
    Yuan R; Venitz J
    Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin binding to partially purified albumin in renal disease.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Feb; 29(2):203-10. PubMed ID: 7460484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic renal failure on oxaprozin multiple-dose pharmacokinetics.
    Audet PR; Knowles JA; Troy SM; Walker BR; Morrison G
    Clin Pharmacol Ther; 1988 Sep; 44(3):303-9. PubMed ID: 3416552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics in patients with renal failure.
    Maher JF
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver.
    Meijer DK; Van der Sluijs P
    Pharm Weekbl Sci; 1987 Apr; 9(2):65-74. PubMed ID: 3295762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal disease and drug metabolism: an overview.
    Gibson TP
    Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practical aspects of pharmacokinetics in renal failure].
    Orzechowska-Juzwenko K; Janicki AG
    Pol Tyg Lek; 1982 Oct; 37(39):1181-4. PubMed ID: 7163064
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
    Tiula E; Tallgren LG; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of alfentanil in chronic renal failure.
    Chauvin M; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function.
    Reidenberg MM
    Am J Med; 1977 Apr; 62(4):466-70. PubMed ID: 851114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.